Company Dynamics
Diga 3 varieties passed GMP inspection and added 2 new products with marketing qualifications
Release time: 2022-12-12 10:15:00
Browse:0Times
recently,Shandong Food and Drug Evaluation and Inspection CenterThe expert group visited Degas Group to report to our company's API (sildenafil citrate、rivaroxaban)carried out drugsGMPOn-site inspection(Dynamic),For APIs (bupropion hydrochloride)Increased production line drug production licensing andGMPOn-site inspection(dynamic). After on-site inspection and data review,3varietiesByGMPSiteCompliance check。
Among the three products that passed the inspection this time, sildenafil citrate and rivaroxaban are both new products that have passed the inspection for the first time, indicating that these two products have completed the qualification certification from research and development to listing, and are officially qualified for marketing.

Degas Group has always focused on product quality and the construction of the production environment, is the first batch of the country to pass the new version.GMPCertified enterprises, and has passed the United States.FDACertification, KoreaMFDSCertification, JapanPMDACertification, etc., API quality management concept and technical strength has reached the international advanced level.
This timesmooththrough on-site inspection,Will once again enrich the product sales category,Improve the company's production capacity of high-quality drugs and.market competitiveness,ForThe company continues to produce products that meet quality standards.provides a guarantee。